News - Product designed to support development and testing efforts around novel saliva-based SARS-CoV-2 diagnostics
26 January 2021News - Research use only reagents allows detection of SARS-CoV-2, influenza A, and influenza B from a single patient sample
02 February 2021News - Formulated for use with test methods that detect nucleocapsid protein of SARS-CoV-2 virus
01 April 2021News - Authorisation enables qualified laboratories to address SARS-CoV-2 testing demands while providing significant economic advantage when compared to other technologies
20 April 2021News - Assistant Director in LGC's Grant Management Group awarded MBE for services to Covid-19 Research Funding
14 June 2021News - Awarded for efforts in supporting research and development of diagnostics and vaccines for COVID-19
21 June 2021News - Ultra-high throughput technology enables large-scale PCR testing in reposnse to global pandemic
13 July 2021News - Safe, non-infectious, and replication deficient quality solution for Delta variant detection and analysis
17 September 2021News - NML team analysis vital to understanding potential discrepancies in measured viral burden used to manage CoVid-19 pandemic
12 October 2021News - Nexar workflow continues to enable simple, scalable, and cost-effective testing
29 October 2021